Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Receivables (2018 - 2025)

Exagen's Receivables history spans 8 years, with the latest figure at $10.9 million for Q4 2025.

  • For Q4 2025, Receivables rose 39.74% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $10.9 million, up 39.74%, while the annual FY2025 figure was $10.9 million, 39.74% up from the prior year.
  • Receivables reached $10.9 million in Q4 2025 per XGN's latest filing, down from $11.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $17.0 million in Q3 2023 to a low of $6.1 million in Q4 2022.
  • Average Receivables over 5 years is $10.6 million, with a median of $10.2 million recorded in 2021.
  • Peak YoY movement for Receivables: soared 86.29% in 2023, then tumbled 44.92% in 2024.
  • A 5-year view of Receivables shows it stood at $9.7 million in 2021, then tumbled by 37.11% to $6.1 million in 2022, then grew by 8.2% to $6.6 million in 2023, then rose by 18.18% to $7.8 million in 2024, then surged by 39.74% to $10.9 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Receivables are $10.9 million (Q4 2025), $11.1 million (Q3 2025), and $14.3 million (Q2 2025).